Main drug classes in use for AD therapy are acetylcholinesterase inhibitors (AChEIs), which function to increase the availability of acetylcholine, contracting the loss of limbic and neocortical cholinergic innervation in AD [335]. Here, ACHE is linked to Alzheimer disease.